[Hydatidiform mole and gestational trophoblastic disease]

Area of Science:

• Gynecology
• Obstetrics
• Reproductive Endocrinology

Context:

• Hydatiform mole is a rare but potentially life-threatening pregnancy complication.
• Two main types exist: partial and complete, with complete moles having a higher risk of persistent disease.
• Advancements in ultrasonography have increased early, asymptomatic diagnoses.

Purpose:

• To outline current best practices for diagnosing, treating, and monitoring hydatiform mole.
• To highlight the importance of differentiating between partial and complete moles due to differing risks.
• To emphasize updated management strategies, including preferred evacuation methods and follow-up protocols.

Summary:

• Hydatiform mole diagnosis is increasingly incidental due to early pregnancy ultrasonography.
• Vacuum aspiration is the recommended evacuation method; medications inducing uterine contractions should be avoided.
• Post-evacuation management includes hormonal contraception and weekly human chorionic gonadotropin (hCG) monitoring.
• hCG monitoring must utilize assays detecting all molecular forms (intact, hyperglycosylated, free beta subunit, central fragment beta subunit).

Impact:

• Improved patient outcomes through timely and appropriate management of hydatiform mole.
• Reduced risk of complications and persistent trophoblastic disease.
• Standardized follow-up protocols ensure comprehensive monitoring for all patients.
• Enhanced detection of all hCG forms leads to more accurate assessment of disease status.